RAISSA BEHM: Open Payments
NPI 1881190916 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 57 payments from 10 companies in 2025. Trend: 2023 $1,253 · 2024 $1,544 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 28 | $546 |
| Gilead Sciences, Inc. | 10 | $263 |
| Amgen Inc. | 4 | $67 |
| ABBVIE INC. | 3 | $65 |
| Antares Pharma, Inc. | 3 | $51 |
| Novo Nordisk Inc | 2 | $46 |
| Exact Sciences Corporation | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $31 |
Products named: CABENUVA, APRETUDE, DOVATO, OTEZLA, XYOSTED, Wegovy, The Cologuard Plus Collection Kit, MOUNJARO.
Industry payments across TX — which companies pay providers there.
